John A. Scarlett, M.D.

John A. Scarlett, M.D.

Former Chairman of the Board, President and Chief Executive OfficeratGeron· In proxies 2022–2025

Pay in FY2025+21% from the year before · Geron stock -62.7% the same year

John A. Scarlett, M.D. was paid $7.4M in FY2025 (Dec), up 21%. Geron stock fell 62.7% that year.

Pay$100 in the stock at the end of FY21 → $108
Pay is from the Summary Compensation Table of each Geron proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. GeronPublic company · 4 yr
    • Former Chairman of the Board, President and Chief Executive Officer2022 – Present · 4 yrStock in role -27%
  2. Cyclacel Pharmaceuticals, Inc.Public company · 8 yr
    • Director2018 – Present · 8 yrNo stock prices for these years
  3. Chiasma, Inc.Public company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years
  4. Covance Biotechnology Services, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. PDS Biotechnology CorporationPublic company
    • Director? – PresentNo stock prices for these years
  6. CytomX Therapeutics, Inc.Public company · 6 yr
    • Director2016 – 2022 · 6 yrNo stock prices for these years
  7. Edge Therapeutics, Inc.Public company · 6 yr
    • Director2013 – 2019 · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • GeronChair · 12 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?